Differential Gene Expression of BRCA1, ERBB2 and TP53 Biomarkers between Human Breast Tissue and Peripheral Blood Samples of Breast Cancer Patients

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 4, 2016-02 ,pp. : 519-525

Bentham Science Publishers

Access to resources Recommend Favorite

High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer

By Aceto Gitana  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 671-683

Springer Publishing Company

Access to resources Recommend Favorite

Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1 , BRCA2 , and TP53 gene mutations

By Manoukian Siranoush  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 207-215

Springer Publishing Company

Access to resources Recommend Favorite

KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer

By Cicenas Jonas   Kvederaviciute Kotryna   Meskinyte Ingrida   Meskinyte-Kausiliene Edita   Skeberdyte Aiste   Cicenas Jonas  

Cancers, Vol. 9, Iss. 5, 2017-04 ,pp. : 42-42

MDPI

Access to resources Recommend Favorite

The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation

By Valentini Adriana   Lubinski Jan   Byrski Tomasz   Ghadirian Parviz   Moller Pal   Lynch Henry   Ainsworth Peter   Neuhausen Susan   Weitzel Jeffrey   Singer Christian   Olopade Olufunmilayo   Saal Howard   Lyonnet Dominique   Foulkes William   Kim-Sing Charmaine   Manoukian Siranoush   Zakalik Dana   Armel Susan   Senter Leigha   Eng Charis   Grunfeld Eva   Chiarelli Anna   Poll Aletta   Sun Ping   Narod Steven  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 177-185

Springer Publishing Company

Access to resources Recommend Favorite